BioCorRx (BICX) Assets (2010 - 2026)

BioCorRx has disclosed Assets across 17 years of filings, most recently posting $2.3 million for Q1 2026.

• Assets for Q1 2026 came in at $2.3 million, down 65.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.3 million (down 65.82% YoY), and the FY2025 annual result was $2.1 million, up 456.36% from the prior year.
• Assets came in at $2.3 million for Q1 2026 at BioCorRx, up from $2.1 million in the prior quarter.
• In the past five years, Assets ranged from a high of $7.5 million in Q3 2025 to a low of $317444.0 in Q1 2024.
• The 5-year median for Assets is $766594.0 (2022), against an average of $2.0 million.
• Across the five-year window, Assets surged 2042.45% in 2025 and tumbled 65.82% in 2026, its largest moves.
• BioCorRx's Assets stood at $766594.0 in 2022, then sank by 49.27% to $388887.0 in 2023, then fell by 0.76% to $385941.0 in 2024, then jumped by 456.36% to $2.1 million in 2025, then grew by 8.27% to $2.3 million in 2026.
• The last three Assets figures came in at $2.3 million (Q1 2026), $2.1 million (Q4 2025), and $7.5 million (Q3 2025), per Business Quant data.